Provided by Tiger Trade Technology Pte. Ltd.

Insmed

147.60
-0.7100-0.48%
Post-market: 144.65-2.9500-2.00%18:55 EDT
Volume:2.59M
Turnover:383.61M
Market Cap:31.82B
PE:-22.99
High:149.88
Open:148.45
Low:146.26
Close:148.31
52wk High:212.75
52wk Low:60.40
Shares:215.55M
Float Shares:193.00M
Volume Ratio:0.84
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4200
EPS(LYR):-6.4200
ROE:-249.28%
ROA:-28.99%
PB:43.05
PE(LYR):-22.99

Loading ...

Insmed Inc - Phase 2B Birch Study of Brensocatib in Crssnp Did Not Meet Primary or Secondary Efficacy Endpoints

THOMSON REUTERS
·
Dec 18, 2025

Insmed Inc - Acquires Phase 2 Ready Monoclonal Antibody for Potential Respiratory and Immunological & Inflammatory Indications

THOMSON REUTERS
·
Dec 18, 2025

Insmed Provides Clinical and Business Update

THOMSON REUTERS
·
Dec 18, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:00 PM

Reuters
·
Dec 18, 2025

Insmed Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Dec 16, 2025

Insmed Is Maintained at Buy by Goldman Sachs

Dow Jones
·
Dec 16, 2025

Walmart was too late for a Nasdaq-100 spot - but these 6 stocks made the cut

Dow Jones
·
Dec 14, 2025

Seagate, Western Digital And Other Four Companies Will Be Added To Nasdaq 100 Index, While Lululemon, ON Semi, Trade Desk And Other Three Companies Will Be Removed

THOMSON REUTERS
·
Dec 13, 2025

Nasdaq Inc: Alnylam Pharmaceuticals, Ferrovial, Insmed, Monolithic Power Systems, Seagate Technology, Western Digital Will Be Added to Nasdaq 100 Index

THOMSON REUTERS
·
Dec 13, 2025

Insmed CEO William Lewis Reports Disposal of Common Shares

Reuters
·
Dec 06, 2025

BRIEF-Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 04, 2025

Rothschild & Co Redburn Initiates Coverage on Insmed With Buy Rating, $263 Price Target

MT Newswires Live
·
Dec 04, 2025

Insmed Grants Inducement Awards to 92 New Employees Under 2025 Plan

Reuters
·
Dec 04, 2025

Insmed Chief Medical Officer Martina Flammer Reports Disposal of Common Shares

Reuters
·
Dec 04, 2025

Insmed Director Elizabeth M. Anderson Reports Sale of Common Shares

Reuters
·
Nov 27, 2025

A Look at Insmed's (INSM) Valuation Following Landmark EU Approval for BRINSUPRI

Simply Wall St.
·
Nov 23, 2025

These 15 stocks are still showing momentum - and a market-beating edge

Dow Jones
·
Nov 21, 2025

Insmed’s Brinsupri Approval and Strategic Market Expansion Justify Buy Rating

TIPRANKS
·
Nov 20, 2025

Jefferies Sticks to Their Buy Rating for Insmed (INSM)

TIPRANKS
·
Nov 19, 2025

Insmed’s BRINSUPRI Approved by European Commission

TIPRANKS
·
Nov 19, 2025